In the intricate environment of living cells, the organization and regulation of ribonucleoprotein (RNP) granules are vital to cellular function and stress response. Central to this regulatory network is RNA-driven condensation, a process by which RNA molecules facilitate the formation of biomolecular condensates—dynamic, membraneless compartments that orchestrate biochemical reactions and molecular assemblies. Recent investigations have illuminated that disruptions in RNA condensation, especially involving repeat-expanded RNA sequences, are implicated in a range of severe neurological disorders, underscoring the pathological importance of RNA aggregation mechanisms.
A groundbreaking study led by Mahendran, Wadsworth, Singh, and colleagues uncovers critical insights into how biomolecular condensates contribute to irreversible RNA aggregation. Contrary to previous assumptions that RNA molecules remain dynamically fluid within condensates, this research reveals that both physiologically relevant RNA sequences and those associated with disease spontaneously undergo an age-dependent percolation transition when inside multi-component condensates. This transition marks a fundamental shift where initially dispersed RNA molecules begin forming nanoscale, homotypic clusters—aggregates of identical RNA sequences—that serve as nuclei for further structural reorganization.
The formation of these homotypic RNA clusters is not merely a passive physical event but actively drives the emergence of complex multi-phasic condensate architectures. At the core, an RNA-rich solid-like phase forms, surrounded by an RNA-depleted fluidic shell, creating a spatially heterogeneous environment within what was once thought to be a homogenous droplet. Such phase separation inside condensates represents a liquid-to-solid transition that could have far-reaching biochemical and physiological consequences, including altering the accessibility of RNA to cellular machinery and potentially contributing to aggregation-linked pathologies.
.adsslot_GDlU6bFXx7{ width:728px !important; height:90px !important; }
@media (max-width:1199px) { .adsslot_GDlU6bFXx7{ width:468px !important; height:60px !important; } }
@media (max-width:767px) { .adsslot_GDlU6bFXx7{ width:320px !important; height:50px !important; } }
ADVERTISEMENT
Critically, the timescale over which these RNA clusters form is intricately dictated by specific molecular parameters: the RNA sequence itself, its secondary structural elements, and notably, the length of nucleotide repeats. The researchers found that variations in these attributes modulate clustering kinetics, highlighting a direct molecular basis for the susceptibility of certain repeat-expanded RNAs associated with neurodegenerative diseases. This finding illuminates how subtle differences in RNA molecular architecture translate into pronounced biophysical behaviors inside condensates.
Beyond the RNA molecules alone, the study sheds light on the influential role of RNA-binding proteins, particularly G3BP1—a core scaffold protein of stress granules. G3BP1 exerts heterotypic buffering effects that counterbalance the intrinsic homotypic attractions among RNA molecules. Remarkably, this protein interference mechanism operates independently of ATP hydrolysis, suggesting a passive yet crucial chaperone-like function whereby G3BP1 prevents or delays the formation of irreversible RNA clusters. Such activity provides cellular proteostasis with an additional layer of RNA phase transition control, safeguarding against dysregulated RNA aggregation.
The implications of these discoveries resonate across cell biology and molecular pathology. By positioning biomolecular condensates as dual-functioning entities—both as orchestrators of normal RNA metabolism and as potential sites of pathological RNA aggregation—the study challenges prevailing paradigms and encourages revisiting the biophysical underpinnings of RNA-centric diseases. Indeed, many neurological disorders marked by repeat RNA expansions, such as certain ataxias and amyotrophic lateral sclerosis, might stem from aberrant phase transitions within condensate cores, providing new avenues for therapeutic intervention.
Technically, the researchers employed advanced imaging techniques and biophysical assays to probe the molecular landscape inside condensates over time. They meticulously characterized how homotypic RNA clustering progresses, employing fluorescence correlation spectroscopy and super-resolution microscopy to resolve nanoscale aggregates otherwise invisible in conventional assays. Through these approaches, they revealed a time-dependent increase in RNA cluster size and density, correlating molecular features with emergent condensate morphology and material properties.
Moreover, the study contributes fundamentally to our understanding of percolation theory in a biological context. Traditionally a concept rooted in physics and material sciences, percolation describes the sudden emergence of an infinite cluster upon reaching a critical threshold of connectivity. Here, the researchers elegantly demonstrate that RNA molecules inside condensates can collectively surpass this connectivity threshold, transitioning the system from a fluid-like to a solid-like state. This conceptual bridge between physics and biology offers a unifying framework to interpret phase behavior in complex molecular assemblies.
Importantly, the results also help clarify the often enigmatic behavior of stress granules under cellular stresses. Stress granules are transient condensates that sequester RNA and proteins to regulate translation during stress. The observation that G3BP1 modulates RNA clustering through heterotypic interactions further refines our model of stress granule dynamics, revealing that specific proteins do not merely scaffold condensates but actively dictate their physicochemical properties by modulating RNA condensation pathways.
In the realm of therapeutic research, these insights pave the way for targeting RNA-binding proteins that function as molecular chaperones within condensates. Therapeutic strategies augmenting or mimicking the buffering activity of proteins like G3BP1 might prevent pathological RNA aggregation without necessitating direct RNA sequence modification—a potentially more feasible and safer intervention. This aligns with broader trends in drug development focused on modulating phase behavior in cells, an emerging frontier in molecular medicine.
Furthermore, the study’s elucidation of repeat expansion length as a determinant of clustering kinetics accentuates the importance of genetic factors in disease manifestation. This connection underscores the potential for genetic screening combined with biophysical profiling to predict disease susceptibility or progression based on molecular phase transition propensities. Such diagnostic tools could significantly enhance precision medicine strategies for neurodegeneration.
While the research primarily elucidates fundamental biophysical phenomena, its broader scientific message bears relevance to RNA biology’s expanding landscape. The paradigm that RNA molecules within condensates behave as passive, inert components is now displaced by a nuanced view recognizing RNA as an active architect of cellular organization—a molecule that can physically transform condensates, influencing function and dysfunction alike. This conceptual evolution will fuel future research investigating RNA’s multifaceted roles in health and disease.
Ultimately, Mahendran and colleagues’ work crystallizes the complex interplay between RNA molecular properties, protein regulators, and condensate material states, forging a new understanding of intracellular phase transitions at the molecular level. By distinguishing the conditions under which RNA condensation remains reversible versus when it veers toward pathological solidification, this study lays the groundwork for deciphering—and perhaps intervening in—the molecular basis of RNA-driven cellular dysfunctions.
As ongoing research continues to unravel the subtle nuances governing biomolecular condensates, the recognition of heterotypic buffering mechanisms and homotypic RNA clustering will doubtlessly inspire novel approaches to manipulate condensate dynamics. Such endeavors will be crucial in combating diseases where aberrant phase transitions play a central role, fundamentally altering our capacity to maintain cellular homeostasis in the face of molecular perturbations.
The integration of biophysical principles, molecular genetics, and cellular biology embodied in this landmark study exemplifies the interdisciplinary spirit propelling modern life sciences. It serves as a guiding beacon for future explorations seeking to delineate the molecular choreography underpinning the liquid-to-solid transitions of biomolecules and their pathological consequences.
Subject of Research: Biomolecular condensates, RNA aggregation, and phase transitions within ribonucleoprotein granules related to neurodegenerative disease mechanisms.
Article Title: Homotypic RNA clustering accompanies a liquid-to-solid transition inside the core of multi-component biomolecular condensates.
Article References:
Mahendran, T.S., Wadsworth, G.M., Singh, A. et al. Homotypic RNA clustering accompanies a liquid-to-solid transition inside the core of multi-component biomolecular condensates. Nat. Chem. (2025). https://doi.org/10.1038/s41557-025-01847-3
Image Credits: AI Generated
Tags: age-dependent percolation transitionbiomolecular condensatescellular function and stress responsecondensate solidification processeshomotypic RNA clustersmulti-component condensatesnanoscale RNA aggregatesneurological disorders and RNAribonucleoprotein granulesRNA aggregation mechanismsRNA sequence repeat expansionRNA-driven condensation
